Cytek Biosciences (CTKB) Revenue Growth (1y) (2021 - 2026)
Cytek Biosciences (CTKB) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.08% |
| 10 | Cytek Biosciences | 565.66 Mn | 499.96 Mn | 21.25 Mn | 6.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.46% |
| Dec 31, 2025 | 8.12% |
| Sep 30, 2025 | 1.54% |
| Jun 30, 2025 | -2.18% |
| Mar 31, 2025 | -7.59% |
| Dec 31, 2024 | -1.30% |
| Sep 30, 2024 | 7.29% |
| Jun 30, 2024 | -6.19% |
| Mar 31, 2024 | 20.96% |
| Dec 31, 2023 | 20.48% |
| Sep 30, 2023 | 18.59% |
| Jun 30, 2023 | 23.74% |
| Mar 31, 2023 | 5.77% |
| Dec 31, 2022 | 24.28% |
| Sep 30, 2022 | 17.75% |
| Jun 30, 2022 | 32.07% |
| Mar 31, 2022 | 44.46% |
| Dec 31, 2021 | 27.03% |
| Sep 30, 2021 | 36.98% |
| Jun 30, 2021 | 58.90% |